Avecho Biotechnology Limited logo

Avecho Biotechnology Limited (AVE)

Market Closed
ASX ASX
- Market Cap
- P/E Ratio
0.67% Div Yield
15.37M Volume
0 Eps
Want to track AVE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Avecho Biotechnology Limited logo
AVE Avecho Biotechnology Limited
28 Jan 2026
-
-
Avecho Biotechnology Limited logo
AVE Avecho Biotechnology Limited
25 Aug 2025
-
-
Avecho Biotechnology Limited logo
AVE Avecho Biotechnology Limited
30 May 2025
-
-
Avecho Biotechnology Limited logo
AVE Avecho Biotechnology Limited
26 Feb 2025
-
-
Avecho Biotechnology Limited logo
AVE Avecho Biotechnology Limited
8 Nov 2024
-
-
Avecho Biotechnology Limited logo
AVE Avecho Biotechnology Limited
29 Aug 2024
-
-
Avecho Biotechnology Limited logo
AVE Avecho Biotechnology Limited
30 May 2024
-
-
Avecho Biotechnology Limited logo
AVE Avecho Biotechnology Limited
29 Feb 2024
-
-
Avecho Biotechnology Limited logo
AVE Avecho Biotechnology Limited
29 Jan 2024
-
-
Avecho Biotechnology Limited logo
AVE Avecho Biotechnology Limited
29 Aug 2016
-
-
Avecho Biotechnology Limited logo
AVE Avecho Biotechnology Limited
29 Feb 2016
-
-
Avecho Biotechnology Limited logo
AVE Avecho Biotechnology Limited
28 Aug 2014
-
-

AVE Earnings Reports FAQ

What is the earnings per share (EPS) for AVE?

The current EPS is 0.

What is the company's earnings growth rate?

Avecho Biotechnology Limited has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Avecho Biotechnology Limited has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Avecho Biotechnology Limited are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for AVE at this time, as Avecho Biotechnology Limited has no recent EPS data to calculate it.